First Trust Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,818
| Closed | -$657K | – | 2621 |
|
|
2024
Q4 | $657K | Sell |
29,818
-58,194
| -66% | -$1.28M | ﹤0.01% | 2168 |
|
|
2024
Q3 | $1.59M | Buy |
88,012
+8,632
| +11% | +$156K | ﹤0.01% | 1855 |
|
|
2024
Q2 | $1.29M | Sell |
79,380
-205,193
| -72% | -$3.33M | ﹤0.01% | 1867 |
|
|
2024
Q1 | $4.02M | Buy |
+284,573
| New | +$4.02M | ﹤0.01% | 1407 |
|
|
2017
Q3 | – | Sell |
-612,724
| Closed | -$20.4M | – | 2456 |
|
|
2017
Q2 | $20.4M | Buy |
612,724
+58,414
| +11% | +$1.94M | 0.05% | 491 |
|
|
2017
Q1 | $17.8M | Buy |
554,310
+29,157
| +6% | +$936K | 0.05% | 555 |
|
|
2016
Q4 | $19M | Buy |
525,153
+158,014
| +43% | +$5.73M | 0.06% | 480 |
|
|
2016
Q3 | $16.9M | Buy |
367,139
+31,720
| +9% | +$1.46M | 0.05% | 517 |
|
|
2016
Q2 | $16.8M | Buy |
335,419
+49,019
| +17% | +$2.46M | 0.05% | 487 |
|
|
2016
Q1 | $15.3M | Buy |
286,400
+143,047
| +100% | +$7.65M | 0.05% | 487 |
|
|
2015
Q4 | $9.41M | Sell |
143,353
-12,043
| -8% | -$791K | 0.02% | 694 |
|
|
2015
Q3 | $8.77M | Sell |
155,396
-25,642
| -14% | -$1.45M | 0.03% | 723 |
|
|
2015
Q2 | $10.7M | Sell |
181,038
-7,932
| -4% | -$469K | 0.03% | 720 |
|
|
2015
Q1 | $11.8M | Buy |
188,970
+5,924
| +3% | +$369K | 0.03% | 644 |
|
|
2014
Q4 | $10.5M | Buy |
183,046
+63,919
| +54% | +$3.68M | 0.04% | 680 |
|
|
2014
Q3 | $6.4M | Sell |
119,127
-125
| -0.1% | -$6.72K | 0.03% | 900 |
|
|
2014
Q2 | $6.25M | Buy |
119,252
+21,847
| +22% | +$1.15M | 0.03% | 873 |
|
|
2014
Q1 | $5.15M | Sell |
97,405
-22,918
| -19% | -$1.21M | 0.02% | 956 |
|
|
2013
Q4 | $4.82M | Sell |
120,323
-2,507
| -2% | -$100K | 0.02% | 968 |
|
|
2013
Q3 | $4.64M | Buy |
122,830
+14,015
| +13% | +$530K | 0.03% | 920 |
|
|
2013
Q2 | $4.27M | Buy |
+108,815
| New | +$4.27M | 0.03% | 862 |
|